| Today’s Big NewsJan 18, 2024 |
| By James Waldron CG Oncology is hoping to raise $209 million from its upcoming IPO, blazing a trail to the public markets that seems to be enticing more biotechs in the first month of the year. |
|
|
|
By Nick Paul Taylor BridgeBio Pharma is building a war chest for its showdown with Pfizer. Facing a deep-pocketed rival, the biotech has struck a set of financing deals worth up to $1.25 billion to support an anticipated launch and a schedule of phase 3 readouts for other assets. |
By Max Bayer Surrozen has halted the development of its clinical-stage IBD med, due in part to trouble with dose safety. The company says that "several" patients at higher dose levels experienced asymptomatic increases in liver enzymes. |
By Nick Paul Taylor Golden Biotechnology has shared updated data on its mushroom-derived drug candidate in metastatic pancreatic cancer, linking first-line use of the molecule to median overall survival (OS) of 14.1 months. |
|
This whitepaper reveals how to strategically scale processes, offering developers flexibility from 1,000L to an industry-leading 5,000L in a single-use bioreactor. Meticulous optimization ensures high-quality drug products, while expert-led parameter fine-tuning guarantees consistent growth across scales. Explore how suspension cells lead the way, providing a robust and adaptable manufacturing platform for gene therapy breakthroughs. .png)
|
|
By Helen Floersh An AI-driven open science competition held by a Canadian nonprofit and sponsored by the Michael J. Fox Research Foundation has announced the discovery of molecules that could someday lead to new treatments for Parkinson’s disease. |
By Angus Liu Bayer is launching a sweeping business overhaul that will “come at the expense of many managerial employees,” as the German conglomerate sees “no viable alternative.” |
By Andrea Park To comply with the now-reinstated import ban, newly sold Series 9 and Ultra 2 Apple Watch models in the U.S. will no longer offer the blood oxygen measurement feature. |
By Joseph Keenan Immunotherapeutic vaccine developer Vaxxinity is partnering with the University of Central Florida to advance space medicine research. |
By Heather Landi Cancer deaths in the United States are falling, with more than 4 million fewer deaths since 1991. But, this progress is jeopardized by increasing incidence for 6 of the top 10 cancers as the projected number of new diagnoses now tops 2 million for the first time, according to new data from the American Cancer Society. |
Fierce podcasts Don’t miss an episode |
| A growing number of companies are introducing diverse voices to their virtual assistants or speech synthesis systems: Apple’s Siri, Amazon’s Polly, Meta’s Voicebox. But what about diversity of voices in healthcare, where the stakes are higher? |
|
|---|
|
|
Whitepaper The road to digital health innovation is exciting but complex and requires thoughtful navigation; this whitepaper serves as your guide through this process. Sponsored by: S3 Connected Health |
Whitepaper Discover how to effectively classify highly potent APIs and the steps required to develop containment protocols and manufacturing processes that are both safe and efficient. Sponsored by: Catalent |
eBook This e-book explores 7 factors that are critical to the success of emerging biopharma companies, whether they plan to out-license, partner, or launch & commercialize products. It’s an essential resource for emerging companies with products in all stages of development.
Presented by Blue Matter, strategic consultants in the life sciences |
| |
|
